| 000 | 01773 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250515192404.0 | ||
| 264 | 0 | _c20100118 | |
| 008 | 201001s 0 0 fre d | ||
| 022 | _a1769-6658 | ||
| 024 | 7 |
_a10.1016/j.canrad.2009.03.005 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCoquard, R | |
| 245 | 0 | 0 |
_a[Definitive treatment of anal canal carcinoma with radiotherapy: adverse impact of a pre-radiation resection. A retrospective study of 57 patients treated with curative intent]. _h[electronic resource] |
| 260 |
_bCancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique _cDec 2009 |
||
| 300 |
_a715-20 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAnal Canal _xsurgery |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAnus Neoplasms _xmortality |
| 650 | 0 | 4 | _aBrachytherapy |
| 650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xmortality |
| 650 | 0 | 4 | _aChemotherapy, Adjuvant |
| 650 | 0 | 4 |
_aCisplatin _xtherapeutic use |
| 650 | 0 | 4 | _aDose Fractionation, Radiation |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xepidemiology |
| 650 | 0 | 4 | _aPatient Positioning |
| 650 | 0 | 4 | _aRetrospective Studies |
| 700 | 1 | _aCenni, J-C | |
| 700 | 1 | _aArtru, P | |
| 700 | 1 | _aChalabreysse, P | |
| 700 | 1 | _aQueneau, P-E | |
| 700 | 1 | _aTaieb, S | |
| 700 | 1 | _aAlessio, A | |
| 700 | 1 | _aLledo, G | |
| 773 | 0 |
_tCancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique _gvol. 13 _gno. 8 _gp. 715-20 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.canrad.2009.03.005 _zAvailable from publisher's website |
| 999 |
_c19244144 _d19244144 |
||